CO6190619A2 - DERIVATIVES OF 2- QUINOLINONA AND 2-QUINOXALINONA AND ITS USE AS ANTIBACTERIAL AGENTS - Google Patents
DERIVATIVES OF 2- QUINOLINONA AND 2-QUINOXALINONA AND ITS USE AS ANTIBACTERIAL AGENTSInfo
- Publication number
- CO6190619A2 CO6190619A2 CO09068489A CO09068489A CO6190619A2 CO 6190619 A2 CO6190619 A2 CO 6190619A2 CO 09068489 A CO09068489 A CO 09068489A CO 09068489 A CO09068489 A CO 09068489A CO 6190619 A2 CO6190619 A2 CO 6190619A2
- Authority
- CO
- Colombia
- Prior art keywords
- 6alkyl
- 6alkenyl
- 6alkynyl
- optionally substituted
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
1.- Un compuesto de la fórmula (I):o una sal farmaceuticamente aceptable del mismo, en donde el compuesto de la fórmula es sustancialmente libre de una mezcla cis (±) de sus enantiómeros, y en donde A se selecciona a partir de CH y N; D se selecciona a partir de C- R7 y N; en donde al menos uno entre A y D es carbono; E se selecciona a partir de O, NH, y S, en donde: i) E es NH si R8 y R9 juntos forman =O; y ii) E es O o S si R8 y R9 son cada uno H; G se selecciona a partir de O y S; J se selecciona a partir de C- R4 y N; R1 se selecciona a partir de H, halo, ciano, C1-6alquilo, C2-6alquenilo, y C2-6alquinilo R1a y - N(R1a), en donde dichos C1-6alquilo, C2-6alquenilo, y C2-6alquinilo son opcionalmente sustituidos con uno o más R10;R1a en cada ocurrencia se selecciona independientemente a partir de H y C1-6alquilo, en donde dicho C1-6alquilo es opcionalmente sustituido con uno o más R20;R2 se selecciona a partir de halo, ciano, C1-6alquilo, C2-6alquenilo, C2-6alquinilo, -OR2a, -N(R2a) en donde dichos C1-6alquilo, C2-6alquenilo, y C2-6alquinilo son opcionalmente sustituidos con uno o más R20;R2a en cada ocurrencia se selecciona independientemente a partir de H y C1-6alquilo, en donde dicho C1-6alquilo es opcionalmente sustituido con uno o más R20; R3 se selecciona a partir de H, halo, ciano, C1-6alquilo, C2-6alquenilo, y C2-6alquinilo, OR3a y -N(R3a) 2, en donde dichos C1-6alquilo, C2-6alquenilo, y C2-6alquinilo son opcionalmente sustituidos con uno o más R30;R3a en cada ocurrencia se selecciona independientemente a partir de H y C1-6alquilo, en donde dicho C1-6alquilo es opcionalmente sustituido con uno o más R30;R4 se selecciona a partir de H, halo, ciano, -CO2H, C1-6alquilo, C2-6alquenilo, y C2-6 alquinilo, en donde dicho C1- 6alquilo, C2-6alquenilo, y C2-6alquinilo son opcionalmente sustituidos con uno o más R40;R6 se selecciona a partir de fluoro, C1-6alquilo, C2-6alquenilo, C2-6alquinilo, -OR6a, en donde dichos C1-6alquilo, C2-6alquenilo, y C2-6alquinilo son opcionalmente sustituidos con uno o más R60; ...1. A compound of the formula (I): or a pharmaceutically acceptable salt thereof, wherein the compound of the formula is substantially free of a cis (±) mixture of its enantiomers, and wherein A is selected from CH and N; D is selected from C-R7 and N; where at least one between A and D is carbon; E is selected from O, NH, and S, where: i) E is NH if R8 and R9 together form = O; and ii) E is O or S if R8 and R9 are each H; G is selected from O and S; J is selected from C-R4 and N; R1 is selected from H, halo, cyano, C1-6alkyl, C2-6alkenyl, and C2-6alkynyl R1a and -N (R1a), wherein said C1-6alkyl, C2-6alkenyl, and C2-6alkynyl are optionally substituted with one or more R10; R1a at each occurrence is independently selected from H and C1-6alkyl, wherein said C1-6alkyl is optionally substituted with one or more R20; R2 is selected from halo, cyano, C1-6alkyl , C2-6alkenyl, C2-6alkynyl, -OR2a, -N (R2a) wherein said C1-6alkyl, C2-6alkenyl, and C2-6alkynyl are optionally substituted with one or more R20; R2a at each occurrence is independently selected from of H and C1-6alkyl, wherein said C1-6alkyl is optionally substituted with one or more R20; R3 is selected from H, halo, cyano, C1-6alkyl, C2-6alkenyl, and C2-6alkynyl, OR3a and -N (R3a) 2, wherein said C1-6alkyl, C2-6alkenyl, and C2-6alkynyl are optionally substituted with one or more R30; R3a at each occurrence is independently selected from H and C1-6alkyl, wherein said C1-6alkyl is optionally substituted with one or more R30; R4 is selected from H, halo, cyano , -CO2H, C1-6alkyl, C2-6alkenyl, and C2-6 alkynyl, wherein said C1-6alkyl, C2-6alkenyl, and C2-6alkynyl are optionally substituted with one or more R40; R6 is selected from fluoro, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, -OR6a, wherein said C1-6alkyl, C2-6alkenyl, and C2-6alkynyl are optionally substituted with one or more R60; ...
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87018106P | 2006-12-15 | 2006-12-15 | |
US96916307P | 2007-08-30 | 2007-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6190619A2 true CO6190619A2 (en) | 2010-08-19 |
Family
ID=39046831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09068489A CO6190619A2 (en) | 2006-12-15 | 2009-07-02 | DERIVATIVES OF 2- QUINOLINONA AND 2-QUINOXALINONA AND ITS USE AS ANTIBACTERIAL AGENTS |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP2121702A1 (en) |
JP (1) | JP2010513255A (en) |
KR (1) | KR20090090385A (en) |
AR (1) | AR064369A1 (en) |
AU (1) | AU2007331247B2 (en) |
BR (1) | BRPI0720236A2 (en) |
CA (1) | CA2671485A1 (en) |
CL (1) | CL2007003641A1 (en) |
CO (1) | CO6190619A2 (en) |
EC (1) | ECSP099506A (en) |
MX (1) | MX2009006325A (en) |
NO (1) | NO20092655L (en) |
PE (1) | PE20081511A1 (en) |
RU (1) | RU2009126731A (en) |
TW (1) | TW200831517A (en) |
UY (1) | UY30788A1 (en) |
WO (1) | WO2008071961A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
WO2006137485A1 (en) | 2005-06-24 | 2006-12-28 | Toyama Chemical Co., Ltd. | Novel nitrogenated heterocyclic compound and salt thereof |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
AU2009302007B2 (en) | 2008-10-10 | 2015-01-15 | Actelion Pharmaceuticals Ltd | Oxazolidinyl antibiotics |
AR076222A1 (en) | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
EP2646567A4 (en) * | 2010-10-04 | 2014-03-26 | British Columbia Cancer Agency | Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer |
US11440884B2 (en) * | 2017-08-21 | 2022-09-13 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
KR20200043409A (en) | 2017-08-21 | 2020-04-27 | 아카디아 파마슈티칼스 인코포레이티드 | Compounds for the treatment of diseases, salts and methods thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19601265A1 (en) * | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones |
AR040336A1 (en) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND |
JP5314244B2 (en) * | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | Novel nitrogen-containing heterocyclic compounds and salts thereof |
MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
WO2006137485A1 (en) * | 2005-06-24 | 2006-12-28 | Toyama Chemical Co., Ltd. | Novel nitrogenated heterocyclic compound and salt thereof |
JP5171618B2 (en) * | 2006-05-26 | 2013-03-27 | 富山化学工業株式会社 | Novel heterocyclic compounds or salts thereof and intermediates thereof |
WO2008006648A1 (en) * | 2006-06-09 | 2008-01-17 | Glaxo Group Limited | Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials |
GB0613208D0 (en) * | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (en) * | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
PE20081551A1 (en) * | 2006-07-20 | 2009-01-09 | Glaxo Group Ltd | QUINOLONE DERIVATIVES AS ANTIBACTERIALS |
-
2007
- 2007-12-12 TW TW096147437A patent/TW200831517A/en unknown
- 2007-12-13 WO PCT/GB2007/004766 patent/WO2008071961A1/en active Application Filing
- 2007-12-13 BR BRPI0720236-9A2A patent/BRPI0720236A2/en not_active IP Right Cessation
- 2007-12-13 MX MX2009006325A patent/MX2009006325A/en not_active Application Discontinuation
- 2007-12-13 RU RU2009126731/04A patent/RU2009126731A/en not_active Application Discontinuation
- 2007-12-13 CA CA002671485A patent/CA2671485A1/en not_active Abandoned
- 2007-12-13 JP JP2009540854A patent/JP2010513255A/en active Pending
- 2007-12-13 EP EP07848510A patent/EP2121702A1/en not_active Withdrawn
- 2007-12-13 KR KR1020097014660A patent/KR20090090385A/en not_active Application Discontinuation
- 2007-12-13 UY UY30788A patent/UY30788A1/en unknown
- 2007-12-13 AU AU2007331247A patent/AU2007331247B2/en not_active Expired - Fee Related
- 2007-12-14 AR ARP070105641A patent/AR064369A1/en not_active Application Discontinuation
- 2007-12-14 CL CL200703641A patent/CL2007003641A1/en unknown
- 2007-12-14 PE PE2007001798A patent/PE20081511A1/en not_active Application Discontinuation
-
2009
- 2009-07-02 CO CO09068489A patent/CO6190619A2/en not_active Application Discontinuation
- 2009-07-09 EC EC2009009506A patent/ECSP099506A/en unknown
- 2009-07-13 NO NO20092655A patent/NO20092655L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ECSP099506A (en) | 2009-08-28 |
CL2007003641A1 (en) | 2008-09-22 |
AR064369A1 (en) | 2009-04-01 |
AU2007331247A1 (en) | 2008-06-19 |
UY30788A1 (en) | 2008-07-31 |
KR20090090385A (en) | 2009-08-25 |
JP2010513255A (en) | 2010-04-30 |
BRPI0720236A2 (en) | 2013-12-24 |
EP2121702A1 (en) | 2009-11-25 |
TW200831517A (en) | 2008-08-01 |
NO20092655L (en) | 2009-09-02 |
AU2007331247B2 (en) | 2011-10-20 |
MX2009006325A (en) | 2009-07-24 |
WO2008071961A8 (en) | 2009-10-22 |
CA2671485A1 (en) | 2008-06-19 |
RU2009126731A (en) | 2011-01-20 |
WO2008071961A1 (en) | 2008-06-19 |
PE20081511A1 (en) | 2008-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6190619A2 (en) | DERIVATIVES OF 2- QUINOLINONA AND 2-QUINOXALINONA AND ITS USE AS ANTIBACTERIAL AGENTS | |
IS6902A (en) | Non-aryl N-substituted heterocyclic NMDA / NR2B antagonists | |
ECSP055974A (en) | SYNTHESIS OF CHLORIDES OF 4 AMINO-2-BUTENOIL AND ITS USE IN THE PREPARATION OF 3-CYANO QUINOLINAS | |
RS52168B (en) | Piperidine gpcr agonists | |
DOP2012000149A (en) | NEW TRYCLIC COMPOUNDS | |
ATE470662T1 (en) | PIPERAZINYLPYRAZINE COMPOUNDS AS AGONISTS OR ANTAGONISTS AT THE SEROTONIN 5HT-2 RECEPTOR | |
CR9980A (en) | IMIDAZOLINS 4,4,5,5 TETRASUSTITUIDAS | |
UY30499A1 (en) | USEFUL DERIVATIVES OF AMINA AS ANTICANCERIGEN AGENTS | |
TNSN08407A1 (en) | Organic compounds | |
CR8755A (en) | FUSIONATED QUINOLIN DERIVATIVE AND USE OF THE SAME | |
ECSP099638A (en) | NEW ADENINE COMPOUND | |
CR8744A (en) | THERAPEUTIC COMPOUNDS | |
EA200870193A1 (en) | CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION | |
MX2011012628A (en) | Substituted aminopropionic derivatives as neprilysin inhibitors. | |
DE602008004265D1 (en) | TRANS-3-azabicyclo-Ä3.1.0Ü-HEXANE DERIVATIVES | |
PE20051054A1 (en) | HETEROCYCLIC COMPOUNDS USEFUL AS SECRETAGOGS OF GROWTH HORMONE | |
BRPI0821255A2 (en) | Spiroindolinone Derivatives | |
DE602008001983D1 (en) | PYRROLIDINE DERIVATIVES AS DOUBLE NK1 / NK3 RECEPTOR ANTAGONISTS | |
PE20140968A1 (en) | SUBSTITUTED BENZAMIDE DERIVATIVES | |
GT200900026A (en) | DERIVATIVES OF 5,6 -BISARIL-2-PIRIDIN-CARBOXAMIDA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS AS ANTAGONISTS OF UROTENSIN II RECEPTORS | |
NO20064175L (en) | Heterocyclic compound | |
NO20071159L (en) | Prodrug-substituted benzoxazoles as estrogenic agents | |
MX2009011365A (en) | Bridged six-membered ring compounds. | |
NO20052023L (en) | Calcium activated K channel opens with high conductance | |
PE20080207A1 (en) | DERIVATIVES OF 1-N-AMINO-2-IMIDAZOLIDINONES AS INHIBITORS OF THE POTASSIUM CHANNEL Kv1.5 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |